STOCK TITAN

Delixy Holdings (DLXY) Financials

DLXY NASDAQ
FY2025 annual
Net Income -$4.5M -534.1% YoY
EPS (Diluted) -$0.29 -514.3% YoY
Operating Cash Flow -$5.2M -957.0% YoY
Gross Profit $2.5M -40.8% YoY
Market Cap $5.0M as of Oct 30, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 47.3x on $105K equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DLXY SEC filings page.

This page shows Delixy Holdings Limited (DLXY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).

Rhea AI DLXY FY2025

FY2025 shows a balance-sheet-heavy business where shrinking earnings and cash generation now sit against almost no equity cushion.

By FY2025, total liabilities were $24.8M against $24.9M of assets, so the business is financed overwhelmingly by obligations rather than owners’ capital. Equity was only $105K, while the current ratio was 1.0x; that combination points to limited short-term flexibility even though current assets slightly exceeded current liabilities.

Profitability weakened through cost structure: gross profit fell 40.8% in FY2025, while SG&A rose 97.0%. That mismatch turned FY2024 operating income of $706K into a FY2025 operating loss of $4.5M, indicating that overhead was not absorbed by the reported gross profit.

Receivables reached $22.4M in FY2025 from $17.5M a year earlier, making working capital a larger claim on the asset base. Operating cash flow simultaneously shifted from $612K to -$5.2M, so reported earnings did not translate into cash as the balance sheet expanded.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Delixy Holdings Limited does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
0/6

Delixy Holdings Limited passes 0 of 6 computable financial strength tests (3 of the nine could not be computed from available data). No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

Delixy Holdings Limited reported a net loss of $4.5M while operations used $5.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Delixy Holdings Limited reported an operating loss of $4.5M against $7K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$4.5M
YoY-534.1%

Delixy Holdings Limited reported a net loss of $4.5M in fiscal year 2025. This represents a decrease of 534.1% from the prior year.

EPS (Diluted)
-$0.29
YoY-514.3%

Delixy Holdings Limited earned -$0.29 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 514.3% from the prior year.

Revenue

Not reported for fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
$1.8M
YoY-46.4%

Delixy Holdings Limited held $1.8M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.

Shares Outstanding
16M
YoY+9.0%

Delixy Holdings Limited had 16M shares outstanding in fiscal year 2025. This represents an increase of 9.0% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-4250.5%
YoY-4326.5pp

Delixy Holdings Limited's ROE was -4250.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4326.5 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

DLXY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLXY annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-F
RevenueN/AN/AN/A$319.8M
Cost of RevenueN/AN/AN/A$317.4M
Gross Profit$2.5M-40.8%$4.3M+4.1%$4.1M+72.3%$2.4M
SG&A Expenses$7.1M+97.0%$3.6M+19.5%$3.0M+37.9%$2.2M
Operating Income-$4.5M-742.1%$706K-37.1%$1.1M+417.1%$217K
EBITDAN/A$774K-34.9%$1.2M+315.7%$286K
Interest Expense$7K-96.1%$178K+673.9%$23K+91.7%$12K
Income Tax$136K+38.8%$98K-56.4%$225K+226.1%$69K
Net Income-$4.5M-534.1%$1.0M-10.8%$1.2M+355.3%$253K
EPS (Basic)-$0.29-514.3%$0.07-12.5%$0.08+300.0%$0.02
EPS (Diluted)-$0.29-514.3%$0.07-12.5%$0.08+300.0%$0.02
Diluted Shares (Avg)16M+4.3%15M0.0%15M0.0%15M

Not reported in any period shown, so not listed: R&D Expenses.

DLXY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLXY annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Total Assets$24.9M+5.2%$23.7M+126.6%$10.4MN/A
Current Assets$24.9M+11.7%$22.3M+132.0%$9.6MN/A
Cash & Equivalents$1.8M-46.4%$3.3M-59.5%$8.2M+36.1%$6.1M
Short-Term Investments$0n/m$0n/m$0n/m$0
Accounts Receivable$22.4M+27.9%$17.5M+2357.1%$713KN/A
Long-Term Investments$0n/m$0n/m$0n/m$0
Total Liabilities$24.8M+11.1%$22.3M+158.9%$8.6MN/A
Current Liabilities$24.8M+43.4%$17.3M+100.8%$8.6MN/A
Non-Current Liabilities$0-100.0%$5.0M+71585.7%$7KN/A
Total Equity$105K-92.2%$1.4M-25.9%$1.8M-84.7%$11.9M
Retained Earnings-$3.9M-729.2%$612K-43.5%$1.1MN/A

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

DLXY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLXY annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Operating Cash Flow-$5.2M-957.0%$612K-84.9%$4.0Mn/m-$4.9M
Depreciation & AmortizationN/A$68K+1.5%$67K-2.9%$69K
Investing Cash Flow$160K-71.0%$552Kn/m-$188K-107.0%$2.7M
Financing Cash Flow$3.5Mn/m-$6.1Mn/m-$1.7Mn/m-$458K
Dividends PaidN/A$4.7M+216.3%$1.5MN/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.

DLXY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLXY annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-F
Gross MarginN/AN/AN/A0.8%
Operating MarginN/AN/AN/A0.1%
Net MarginN/AN/AN/A0.1%
Return on Equity-4250.5%-4326.5pp76.0%+12.9pp63.1%+61.0pp2.1%
Return on Assets-17.9%-22.3pp4.3%-6.7pp11.0%N/A
Current Ratio1.00-0.3x1.29+0.2x1.12N/A
Liabilities-to-Equity236.03+219.5x16.48+11.8x4.72N/A

Not reported in any period shown, so not listed: Debt-to-Equity, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Delixy Holdings Limited DLXY FY2025 N/A -$4.5M N/A $5.0M —
Star Group, L.P. Common Units SGU FY2025 $1.8B $73.5M 4.1% $424.6M 43/100
World Kinect Corporation WKC FY2025 $36.9B -$614.4M -1.7% $1.9B 26/100
CrossAmerica Partners LP Common units CAPL FY2025 $3.7B N/A N/A $859.3M 32/100
Clean Energy Fuels Corp. CLNE FY2025 $424.8M -$222.0M -52.3% $317.4M 47/100

Frequently Asked Questions

No, Delixy Holdings Limited (DLXY) reported a net loss of $4.5M in fiscal year 2025.

Delixy Holdings Limited (DLXY) reported diluted earnings per share of -$0.29 for fiscal year 2025. This represents a -514.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Delixy Holdings Limited (DLXY) has a return on equity of -4250.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Delixy Holdings Limited (DLXY) recorded an outflow of $5.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Delixy Holdings Limited (DLXY) had $24.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Delixy Holdings Limited (DLXY) had 16M shares outstanding as of fiscal year 2025.

Delixy Holdings Limited (DLXY) had a current ratio of 1.00 as of fiscal year 2025, which is considered adequate.

Delixy Holdings Limited (DLXY) had a liabilities-to-equity ratio of 236.03 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Delixy Holdings Limited (DLXY) had a return on assets of -17.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Delixy Holdings Limited (DLXY) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $5.0M as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Delixy Holdings Limited (DLXY) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $5.0M as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Delixy Holdings Limited (DLXY) held $1.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.2M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Delixy Holdings Limited (DLXY) has a Piotroski F-Score of 0 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Delixy Holdings Limited (DLXY) reported a net loss of $4.5M while operations used $5.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Delixy Holdings Limited (DLXY) reported an operating loss of $4.5M against $7K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top